Business
Practice ManagementMalpractice ConsultHealth Law & Policy
Media
Case-Based Peer PerspectivesInvestigator Perspectives Medical World NewsPodcastsUrology Medical PerspectivesUTv VideosPeer ExchangeSpecial ReportVirtual Tumor BoardInsightsMedcastPeers & Perspectives
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Urology Times JournalEditorial Advisory BoardUrologists in Cancer CareSupplements and Featured PublicationsClinical Forums Recaps
More
CME/CE
Resources
Begin Your Journey: Tackling BurnoutSponsored MediaLive EventsInteractive ToolsJob BoardPartnersSponsored ResourcesTreatment Landscape Evolutions

Subscribe

  • Business
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Benign Conditions
  • Benign Prostatic Hyperplasia
  • Bladder Cancer
  • Female Urology
  • Genitourinary Cancers
  • Genomic Testing
  • Hormone Therapy
  • Kidney Cancer
  • Kidney Stones
    • Challenging Anatomy
  • Men's Health
  • Next-Generation Imaging
  • OAB and Incontinence
    • Voiding Dysfunction
  • Pediatrics
  • Prostate Cancer
    • Controveries in Urologic Cancer
    • Drug Therapy
  • Sexual Dysfunction
  • UTUC
  • Urologic Surgery
    • Cosmetic Surgery
Spotlight -
Peer Exchange|
Peers and Perspectives|
Case-Based Peer Perspectives|
Urology Times Journal
Advertisement

Rainjade Chung, MD

Advertisement

Chung is a resident at NewYork-Presbyterian/Columbia University Irving Medical Center, New York, New York.

Articles by Rainjade Chung, MD

Kateryna_Kon - stock.adobe.com

Management of hormone-naïve oligometastatic prostate cancer

ByMichael Smigelski, MD,Rainjade Chung, MD,Christopher B. Anderson MD, MPH
November 23rd 2021

Growing evidence supports the existence of an intermediate metastatic disease state.

Advertisement

Latest Updated Articles

  • Kateryna_Kon - stock.adobe.com
    Management of hormone-naïve oligometastatic prostate cancer

    Published: November 23rd 2021 | Updated:



Advertisement
Advertisement

Trending on Urology Times

1

FDA grants clearance to Hugo robotic-assisted surgery system for urologic procedures

2

Apalutamide is linked to fewer CNS-related conditions in patients with nmCRPC

3

Prostate MRI is linked with higher sensitivity, NPV vs micro-ultrasound in pilot study

4

BOND-003: Cretostimogene yields durable 24-month responses in high-grade NMIBC

5

Michael Cookson, MD, discusses new strategies for treatment intensification in prostate cancer

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do not sell my Personnal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us